Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception
about
What's new for antiretroviral treatment in women with HIVEffectiveness and safety of oral HIV preexposure prophylaxis for all populationsSafety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.PrEP as Peri-conception HIV Prevention for Women and Men.Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trialUptake and effectiveness of PrEP for transgender womenOffering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approachRepeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+ T cells.Recent advances in pre-exposure prophylaxis for HIV.Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya
P2860
Q30391322-C3A5678A-58BB-42F9-8B0E-83099D0B76FDQ34677217-1ABC9550-81CB-4B90-B476-F216C0224F0FQ36586078-162A20DB-F124-452F-89FF-5D82ECEAD41DQ36963511-B3F5D4C8-A12F-4DC2-BF89-624D785E1504Q37114554-C7B0844D-CDEB-4D61-8E85-DBED629B3E9AQ37143392-6B973A57-D015-4CF5-94F8-4B611167A4B7Q37418247-7982821E-4587-48F2-8478-058E68E9524FQ37663053-04006179-2432-4668-BFA3-5A7F3ED17799Q38737364-EADAA730-F173-4C82-806E-C2052F21B6C3Q40106510-95074D5A-F953-4CF1-B5E3-36FDC759D100Q40517790-6A41F5C0-EA11-4F3C-B1D9-333F2E1F55EDQ47151161-F588DA41-614A-47E5-8302-1FAFB28FE444Q49921922-2CB1A758-A337-42F1-A631-7BE763A2ECD6Q58765180-0F720F67-C9CE-4878-950A-23C6C434A355
P2860
Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preexposure prophylaxis is eff ...... rone acetate for contraception
@ast
Preexposure prophylaxis is eff ...... rone acetate for contraception
@en
Preexposure prophylaxis is eff ...... rone acetate for contraception
@nl
type
label
Preexposure prophylaxis is eff ...... rone acetate for contraception
@ast
Preexposure prophylaxis is eff ...... rone acetate for contraception
@en
Preexposure prophylaxis is eff ...... rone acetate for contraception
@nl
prefLabel
Preexposure prophylaxis is eff ...... rone acetate for contraception
@ast
Preexposure prophylaxis is eff ...... rone acetate for contraception
@en
Preexposure prophylaxis is eff ...... rone acetate for contraception
@nl
P2093
P2860
P50
P1433
P1476
Preexposure prophylaxis is eff ...... rone acetate for contraception
@en
P2093
Andrew Mujugira
Edwin Were
James Kiarie
Jared M Baeten
Lisa M Frenkel
Nelly Mugo
Partners PrEP Study Team
Renee Heffron
P2860
P304
P356
10.1097/QAD.0000000000000493
P407
P577
2014-11-01T00:00:00Z